These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33506245)

  • 1. Medical costs of Japanese lung cancer patients during end-of-life care.
    Awano N; Izumo T; Inomata M; Kuse N; Tone M; Takada K; Muto Y; Fujimoto K; Kimura H; Miyamoto S; Igarashi A; Kunitoh H
    Jpn J Clin Oncol; 2021 Apr; 51(5):769-777. PubMed ID: 33506245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosis.
    Awano N; Izumo T; Inomata M; Kuse N; Tone M; Takada K; Muto Y; Fujimoto K; Kimura H; Miyamoto S; Igarashi A; Kunitoh H
    Jpn J Clin Oncol; 2021 Apr; 51(5):778-785. PubMed ID: 33506249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Guideline-Recommended Initiation of Therapy, Outcomes, and Cost for Patients with Metastatic Non-Small Cell Lung Cancer.
    Casebeer A; Antol DD; DeClue RW; Hopson S; Li Y; Khoury R; Michael T; Sehman M; Parikh A; Stemkowski S; Bunce M
    J Manag Care Spec Pharm; 2018 Jun; 24(6):554-564. PubMed ID: 29799325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.
    Bremner KE; Krahn MD; Warren JL; Hoch JS; Barrett MJ; Liu N; Barbera L; Yabroff KR
    Palliat Med; 2015 Dec; 29(10):918-28. PubMed ID: 26330452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
    Kwan SW; Mortell KE; Hippe DS; Brunner MC
    J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience.
    Zeng X; Karnon J; Wang S; Wu B; Wan X; Peng L
    PLoS One; 2012; 7(10):e48323. PubMed ID: 23118985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing costs of metastatic non small cell lung cancer in the Netherlands.
    Keusters WR; de Weger VA; Hövels A; Schellens JHM; Frederix GWJ
    Lung Cancer; 2017 Dec; 114():56-61. PubMed ID: 29173766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
    Cipriano LE; Romanus D; Earle CC; Neville BA; Halpern EF; Gazelle GS; McMahon PM
    Value Health; 2011 Jan; 14(1):41-52. PubMed ID: 21211485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of care associated with non-small-cell lung cancer in a commercially insured cohort.
    Hillner BE; McDonald MK; Desch CE; Smith TJ; Penberthy LT; Maddox P; Retchin SM
    J Clin Oncol; 1998 Apr; 16(4):1420-4. PubMed ID: 9552046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
    Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
    J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.
    Karve SJ; Price GL; Davis KL; Pohl GM; Smyth EN; Bowman L
    BMC Health Serv Res; 2014 Nov; 14():555. PubMed ID: 25392276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States.
    Haque W; Verma V; Butler EB; Teh BS
    Anticancer Res; 2019 Jun; 39(6):3137-3140. PubMed ID: 31177159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
    Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
    Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical care costs of cancer in the last year of life using national health insurance data in Korea.
    Park M; Song I
    PLoS One; 2018; 13(6):e0197891. PubMed ID: 29879136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study.
    Naito T; Okayama T; Aoyama T; Ohashi T; Masuda Y; Kimura M; Shiozaki H; Murakami H; Kenmotsu H; Taira T; Ono A; Wakuda K; Imai H; Oyakawa T; Ishii T; Omori S; Nakashima K; Endo M; Omae K; Mori K; Yamamoto N; Tanuma A; Takahashi T
    BMC Cancer; 2017 Nov; 17(1):800. PubMed ID: 29183277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Bittoni MA; Arunachalam A; Li H; Camacho R; He J; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e629-e645. PubMed ID: 29885945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active anticancer treatment during the final month of life in patients with non-small cell lung cancer.
    Nieder C; Tollåli T; Dalhaug A; Haukland E; Aandahl G; Pawinski A; Norum J
    Anticancer Res; 2014 Feb; 34(2):1015-20. PubMed ID: 24511048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and costs of treating lung cancer patients in a university hospital.
    Dedes KJ; Szucs TD; Bodis S; Joerger M; Lowy A; Russi EW; Steinert HC; Weder W; Stahel RA
    Pharmacoeconomics; 2004; 22(7):435-44. PubMed ID: 15137882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.